Curcumin triggers reactive oxygen species-mediated apoptosis and suppresses tumor growth in metastatic oral squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Curcumin triggers reactive oxygen species-mediated apoptosis and suppresses tumor growth in metastatic oral squamous cell carcinoma.
Authors: Ramos TCF; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Department of Propedeutics, School of Dentistry of the Federal University of Bahia, Salvador, Brazil.; Department of Health, School of Dentistry of the State University of Feira de Santana, Feira de Santana, Brazil., Dias RB; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Department of Propedeutics, School of Dentistry of the Federal University of Bahia, Salvador, Brazil.; Department of Biological Sciences, State University of Feira de Santana, Feira de Santana, Brazil., Santos LS; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Center for Biotechnology and Cell Therapy, D'Or Institute for Research and Education (IDOR), São Rafael Hospital, Salvador, Brazil., Valverde LF; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Department of Dentistry, Federal University of Sergipe, Lagarto, Brazil., Nogueira RLR; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Department of Pathology and Legal Medicine, School of Medicine of the Federal University of Bahia, Salvador, Brazil., Bastos IN; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Department of Propedeutics, School of Dentistry of the Federal University of Bahia, Salvador, Brazil.; Center for Biotechnology and Cell Therapy, D'Or Institute for Research and Education (IDOR), São Rafael Hospital, Salvador, Brazil., Coletta RD; Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, Brazil., Soares MBP; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Institute of Innovation in Advanced Health Systems (ISI SAS), University SENAI/CIMATEC, Salvador, Brazil., Souza BSF; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Center for Biotechnology and Cell Therapy, D'Or Institute for Research and Education (IDOR), São Rafael Hospital, Salvador, Brazil.; Department of Pathology and Legal Medicine, School of Medicine of the Federal University of Bahia, Salvador, Brazil., Dos Santos JN; Department of Propedeutics, School of Dentistry of the Federal University of Bahia, Salvador, Brazil., Dos Reis MG; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Department of Pathology and Legal Medicine, School of Medicine of the Federal University of Bahia, Salvador, Brazil., Bezerra DP; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil., Gurgel CA; Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Brazil.; Department of Propedeutics, School of Dentistry of the Federal University of Bahia, Salvador, Brazil.; Center for Biotechnology and Cell Therapy, D'Or Institute for Research and Education (IDOR), São Rafael Hospital, Salvador, Brazil.; Department of Pathology and Legal Medicine, School of Medicine of the Federal University of Bahia, Salvador, Brazil.
Source: Frontiers in oncology [Front Oncol] 2025 Oct 10; Vol. 15, pp. 1668271. Date of Electronic Publication: 2025 Oct 10 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1668271